CONFERENCE CONTRIBUTIONS

ORAL PRESENTATIONS ON INTERNATIONAL CONFERENCES

International Congress of Neuroendocrinology, BSN, August 7-10, 2022, Glasgow, United Kingdom “Translational Significance of the Prolactin/Vasoinhibin Axis on the Example of Diabetic Retinopathy”

The Growth Hormone / Prolactin Family in Biology & Disease Conference, FASEB, July 7-12, 2019, West Palm Beach, Florida: “Novel Perspectives on the Determination of Vasoinhibin in Patients”

German Congress for Endocrinology, German Society for Endocrinology (DGE), March 14-16, 2018, Bonn, Germany: “From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis”

73rd Scientific Sessions of the American Diabetes Association (ADA), June 21-25, 2013, Chicago, Illinois: “Lower vitreal generation and higher renal elimination of vasoinhibins in patients with proliferative diabetic retinopathy”

POSTER PRESENTATIONS ON INTERNATIONAL CONFERENCES

Society for Endocrinology BES 2023 Conference, Glasgow, November 13-15 “Immunometric and functional measurement of endogenous vasoinhibin in human sera“ https://doi.org/10.1530/endoabs.94.P111

22nd European Congress of Endocrinology, Online, September 5-9, 2020: Vasoinhibin dimerization and measurement in human sera with a new vasoinhibin elisa https://doi.org/10.1530/endoabs.70.AEP543

62. German Congress for Endocrinology, Göttingen, Germany, March 20-22, 2019: Plasmin cleaves prolactin and placental lactogen and generates vasoinhibin-like peptides

18th European Congress of Endocrinology, Munich, Germany, May 28-31, 2016: Serum proteases do not cleave prolactin to vasoinhibins at physiological pH

18th European Congress of Endocrinology, Munich, Germany, May 28-31, 2016: The vasoinhibin solution structure appears unfolded, dynamic, and features aggregation

Society for Molecular Biology and Evolution Conference 2016, Broadbeach, Australia, July 3-7, 2016: The number of prolactin cleavage sites generating vasoinhibins varies in primates

16th European Congress of Endocrinology, Wroclaw, Poland, May 3-7, 2014: Vasoinhibins are natural inhibitors of angiogenesis in the vitreous and are impaired in patients with diabetic retinopathy

The Growth Hormone/Prolactin Family in Biology and Disease, FASEB, July 8-13, 2012, Snowmass Village, Colorado, U.S.A. Higher urinary vasoinhibin excretion in patients with proliferative diabetic retinopathy

64. Annual Meeting of the DGVS, September 30 – October 3, 2009, Hamburg, Germany: Analyse von 16K Prolaktin im Serum von Patienten mit diabetischer Retinopathie (GER) / Analysis of 16K prolactin in sera of patients with diabetic retinopathy